Welcome to our dedicated page for Goldman Sachs Group news (Ticker: GS), a resource for investors and traders seeking the latest updates and insights on Goldman Sachs Group stock.
The Goldman Sachs Group, Inc. reports news across its investment banking, global markets, lending, asset management and wealth management businesses. Recurring developments include earnings releases, capital and debt-market activity, governance updates, and disclosures tied to its listed common stock, preferred depositary shares, capital securities and medium-term notes.
Company news also includes activity from Goldman Sachs Asset Management, Goldman Sachs Alternatives and related investment platforms, including growth-equity investments, enterprise technology financings, AI-focused partnerships and specialty-finance vehicles externally managed by Goldman Sachs Asset Management. These updates reflect the firm’s role as a global financial institution, asset manager and capital provider.
Goldman Sachs BDC, Inc. (GSBD) reported financial results for Q4 and FY 2022, announcing a net investment income of $0.66 per share, with an adjusted yield of 17.8%. The earnings per share for the quarter was $0.04, while net asset value per share decreased by 2.7% to $14.61. Total investments at fair value were $3.88 billion with a significant majority in senior secured debt (97.6%). A regular dividend of $0.45 per share has been declared for Q1 2023. Notably, net expenses rose to $36.9 million, influenced by increased interest rates.
The Goldman Sachs MLP and Energy Renaissance Fund (NYSE: GER) has announced a quarterly distribution of $0.220 per common share, a 10% increase from the previous quarter. This distribution is payable on February 28, 2023, with the ex-date on February 21 and record date on February 22. A portion of this distribution may be treated as a return of capital for tax purposes, with final determinations made in 2023. Portfolio Manager Kyri Loupis emphasized the commitment to return income to shareholders. The Fund focuses on master limited partnerships and energy investments, seeking high total returns.
Star Mountain Capital has appointed George Mattson as President, a newly created position, to enhance its growth and performance. Mattson, a former partner at Goldman Sachs with 35 years of experience, will also serve on the firm's Investment and Executive Committees. With approximately $3.5 billion in assets under management, Star Mountain focuses on investments in established lower middle-market businesses. The firm has made about 200 direct investments since 2010, emphasizing the creation of jobs and economic development in North America.
Crux has reported significant growth and momentum in 2022, highlighted by $75M in contractual sales commitments and a remarkable annual recurring revenue (ARR) growth exceeding 260%. The company secured $50M in new venture funding, raising its total to $157M, led by Goldman Sachs and Two Sigma. By establishing over 260 partnerships with major data and cloud marketplaces, including Google, Crux's influence in external data technology continues to rise. Their newly introduced External Data Platform aims to democratize data integration, enhancing operational efficiency for clients worldwide.
A joint venture between Goldman Sachs Asset Management and Lane Partners has successfully completed the recapitalization of Southline Phase I, a prominent life science development in South San Francisco. This project, located near public transit options, will consist of two buildings totaling over 715,000 square feet, offering innovative spaces for life science and technology firms. Construction financing has been secured through Square Mile Capital and Bank OZK. The project aims to enhance tenant growth and is positioned within a key life science cluster, reflecting confidence in the Bay Area market.
Shanghai LePure Biotech Co., Ltd. has successfully completed its Series C financing, raising funds from renowned investors including Novo Holdings, General Atlantic, and Goldman Sachs Asset Management. The financing will bolster product innovation, accelerate overseas expansion, and enhance competitiveness in the global market.
Founded in 2011, LePure specializes in single-use bioprocessing solutions for macromolecular drug manufacturing. The recent acquisition of QuaCell Biotechnology enables LePure to expand its product suite, now including cell culture media alongside existing solutions. The company is poised to leverage its first-mover advantage and expertise to respond to market demands.
Goldman Sachs BDC, Inc. (NYSE: GSBD) will announce its financial results for the fourth quarter and fiscal year ended December 31, 2022 on February 23, 2023, post-market close. An earnings conference call is scheduled for February 24, 2023, at 9:00 am ET. All stakeholders can join via telephone or through the audio webcast available on GS BDC’s website. The company focuses on investing in middle-market firms primarily through various debt instruments and is externally managed by Goldman Sachs Asset Management.
Summary not available.
Goldman Sachs has partnered with CAF Funds to acquire 2,766 units in Texas, expanding their affordable housing initiative to a total of 3,800 units. This acquisition will support CAF's ‘Impact + Housing’ platform, aiming to provide essential social programs like childcare and financial literacy to residents. Freddie Mac recognized CAF's commitment to social impact by awarding it an Impact Sponsor designation. The partnership also focuses on enhancing affordability and sustainability through environmental audits and energy-efficient upgrades.
Goldman Sachs Asset Management, alongside Lincoln Harris, has acquired a 445,000-square-foot life science campus in the rapidly growing Raleigh-Durham area. The campus, located at Stirrup Creek Drive in the Research Triangle Park, consists of five buildings and is home to notable companies in the life sciences field. The property has undergone extensive upgrades, including a new 14,000-square-foot amenity center with a fitness center and recreational space. Future plans include additional improvements tailored to life science tenants, enhancing its appeal in this dynamic sector.